Polydex Pharmaceuticals Ltd (POLXF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 01/31
| 01-2013 | 01-2012 | 01-2011 | 01-2010 | 01-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -420 | 230 | -690 | -2,140 | -1,590 |
| Depreciation Amortization | 170 | 260 | 310 | 430 | 540 |
| Other Working Capital | 140 | -70 | 140 | 160 | 240 |
| Other Operating Activity | 60 | 40 | 90 | 960 | 560 |
| Operating Cash Flow | $-50 | $460 | $-150 | $-590 | $-250 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -110 | -150 | -60 | -60 | -50 |
| Other Investing Activity | -10 | -10 | 320 | 70 | 380 |
| Investing Cash Flow | $-120 | $-160 | $260 | $10 | $330 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 130 | -270 | -100 | 140 | -100 |
| Financing Cash Flow | $130 | $-270 | $-100 | $140 | $-100 |
| Exchange Rate Effect | 10 | -2 | -6 | 100 | -110 |
| Beginning Cash Position | 30 | 2 | 7 | 320 | 460 |
| End Cash Position | 4 | 30 | 2 | 7 | 320 |
| Net Cash Flow | $-20 | $30 | $-5 | $-320 | $-140 |
| Free Cash Flow | |||||
| Operating Cash Flow | -50 | 460 | -150 | -590 | -250 |
| Free Cash Flow | -50 | 460 | -150 | -590 | -250 |